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ST-elevation myocardial infarction: Are the
results of femoral operators unfairly
represented in observational research?
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Adnan Khan, MRCP, d and Rod H Stables, DM, FRCP a Liverpool Heart and Chest Hospital, Liverpool;
Wythenshawe, Manchester; Scott Lane, Salford; and Agamemnon St, ClydebankBackground Recent randomized controlled trials comparing femoral and radial access in primary percutaneous
coronary intervention (PPCI) have shown conflicting results regarding the incidence of major adverse cardiovascular events
(MACE) and major bleeding.
Methods Using data from the HEAT-PPCI trial, we compared the primary efficacy (all-cause mortality, stroke, new
myocardial infarction or unplanned repeat revascularization) and safety (major bleeding BARC 3–5) outcomes at 28 days, by
final access site used (radial or femoral) and by default operator type. We then assessed outcomes in femoral cases performed
by both operator types.
Results Radial access (RA) was associated with fewer MACE (91/1472 = 6.2% vs. 36/332 = 10.8% P = .003) and
major bleeding events (38/1472 = 2.6% vs 22/332 = 6.6% P = .001) when compared to femoral access (FA). When
analyzing outcomes by default operator type, there was a similar incidence of MACE (111/1575 = 7% vs 16/229 = 7%
P = .97) and major bleeding events (49/1575 = 3.1% vs 11/229 = 4.8% P = .18). In cases where FA was performed by
default radial operators, there was a higher rate of MACE (22/122 = 18% vs 14/210 = 6.7% P = .003) and major bleeding
events (11/122 = 9% vs 11/210 = 5.2% P b .001), potentially explained by a higher risk profile in these cases.
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hMajor bleeding after percutaneous coronary intervention
(PCI) is associated with increased mortality and major
adverse cardiovascular events (MACE).1 The choice of
access site may influence the rate of complications and
adverse events following primary PCI (PPCI). Since the
introduction of PPCI as the preferred treatment for
reperfusion in the acute management of ST-elevation
myocardial infarction (STEMI), there has been a shift in
operator preference for radial over femoral access.2-4
However recent trials comparing the two access sites in
PPCI have shown conflicting results regarding the
incidence of MACE and major bleeding.5-8
Previous trials comparing access sites do not consider
the default preference of radial or femoral for each
operator. Therefore, randomization of the access site
alone does not control for the varying experience of
individual operators. The primary aim of this study was to
examine associations between default radial and default
femoral operator type, irrespective of final access site
chosen.
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circumstances by all operators. It is, therefore, important
to establish the safety of the FA when used by both
femoral and radial operators. A secondary aim of this
study was to analyze all FA cases to establish differences
between all operators when performing cases via FA.
Methods
HEAT-PPCI was a single-center, randomized controlled
trial comparing unfractionated heparin versus bivalirudin
in the treatment of patients with suspected STEMI, for
planned management with PPCI (registered at
clinicaltrials.gov NCT01519518).9 The trial recruited
from the Liverpool Heart and Chest Hospital, a high-
volume PPCI center. For individual operators (defined as
participants in the PPCI service, for the duration of the
trial) the annual medial PCI case volume was 218 cases
(range: 158–283), based on data for the financial year
2013–14. Participants were tracked during their index
admission for clinical outcome events and followed up
for 28 days following randomization.
The HEAT-PPCI trial was partially funded by unrestrict-
ed grants from The Medicines Company and AstraZeneca
but these companies had no involvement in any aspect of
trial design, conduct or reporting. The authors are solely
responsible for the design and conduct of this study, all
study analyses, the drafting and editing of the manuscript,
and its final contents.
The primary efficacy outcome of the HEAT-PPCI trial
was the proportion of patients who had at least one
MACE at 28 days. MACE included all-cause mortality,
cerebrovascular accident (CVA), reinfarction or addition-
al unplanned target lesion revascularization. The primary
safety outcome was the proportion of patients who had a
major bleed by 28 days, classified as type 3–5 according
to the Bleeding Academic Research Consortium (BARC).
All outcomes were adjudicated, blinded to the treatment
allocation.
When patients were recruited into the HEAT-PPCI trial,
they were treated by the operator who was assigned to
PPCI activity by a rota system. Over time, this creates a
near-random allocation of patient-types and risk profiles
between operators. The route of arterial access was
determined by operator preference and recorded in the
trial documentation. This allowed analysis of 28-day
outcomes by access site. Operators in the study had
established practice patterns for vascular access that
allowed their categorization as “default femoral” or
“default radial” based on the access site used as their
natural first preference, accounting for over 90% of all
historic and trial-specific activity.
Statistical analysis
Data are presented as (n/ d = p%) for categorical
variables and as means (standard deviations) or medians(interquartile ranges) for continuous variables after
testing for normality. Comparisons between groups
were made using chi-square test for categorical
variables and unpaired t-test or Mann-Whitney U test for
continuous variables. P b .05 (2 sided) was considered
statistically significant. SPSS version 22 (SPSS Inc.,
Chicago, IL, USA) was used for analyses.
Results
Between 7th February 2012 to 20th November 2013,
1829 patients were enrolled into the HEAT-PPCI trial. It
was not possible to obtain consent in 17 cases. Brachial
artery was chosen as the final access site in 2 patients.
Angiography was not attempted in 6 participants. Of the
remaining 1804 cases, RA was used as the final access site
in 1472/1804 = 81.6% cases and FA was used in 332/
1804 = 18.4% cases (Figure 1). In patients where FA
access was used, the access site was closed using an
internal vascular closure device in 215/332 = 64.8% of
cases, manual pressure was used in 105/332 = 31.6% of
cases and 12/332 = 3.6% were not closed because the
patient died during or shortly after the procedure. Table I
details the baseline characteristics and demographics of
the participants categorized by final access site. There
were significant differences between the two groups,
with RA cases having a better risk profile in term of age,
systolic blood pressure, renal function and previous MI/
PCI/CABG. RA cases were also significantly less likely to
have an intra-aortic balloon pump (IABP) used during the
procedure, require venous access or receive glycoprotein
IIb/IIIa inhibitors.
Relationship between final access site and clinical
outcomes
Table II illustrates the clinical outcomes by final access
site. The primary efficacy outcome of MACE occurred in a
significantly higher number of FA cases vs. RA cases (36/
332 = 10.8% vs. 91/1472 = 6.2% P = .003). The 28-day
mortality was higher in the FA cases (27/332 = 8.1% vs.
55/1472 = 3.7% P = .001). The number of major bleed-
ing events was also significantly higher in the FA cases
(22/332 = 6.6% vs. 38/1472 = 2.6% P = .001).
Relationship between operator default access site and
clinical outcomes
Individual default radial operators performed a similar
number of procedures to default femoral operators but,
as there were fewer femoral operators, in total more
radial than femoral procedures were performed, (1575/
1804 = 87.3% vs. 229/1804 = 12.7%) (Figure 2). The
baseline characteristics of the two groups were compa-
rable and are detailed in Table III.
Table IV illustrates the clinical outcomes by operators'
default choice of access site. There was no significant
difference in rates of MACE between procedures
Figure 1
Flow diagram outlining the number of participants where radial and femoral access sites were used.
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(111/1575 = 7% vs. 16/229 = 7% P = .97). The rate of
major bleeding events between the two groups was not
significantly different (49/1575 = 3.1% vs. 11/229 = 4.8%
P = .18).
Relationship between operator default access site and
clinical outcomes in cases where FA was used
A total of 332/1804 cases were performed via FA, with
210/332 = 63.3% performed by default femoral operators
and 122/332 = 36.7% performed by default radial oper-
ators. Table V illustrates the baseline characteristics of the
two groups. Cases where FA was performed by default
radial operators had a significantly higher risk profile in
terms of age, systolic blood pressure, eGFR, previous MI
and PCI. FA cases were significantly more likely to have
required venous access or had an IABP used during the
procedure.
Table VI illustrates the clinical outcomes for the FA
cases by default operator type. FA performed by default
radial operators was associated with a significantly higher
rate of MACE compared to FA performed by default
femoral operators (22/122 = 18% vs. 14/210 = 6.7% P =
.003). Mortality rates at 28 days were significantly higher
in the FA performed by radial operators. Major bleedingevents occurred with more frequency in the FA cases
performed by RA operators (11/122 = 9% vs. 11/210 =
5.2% P b .001).Discussion
The results of this study suggest that there is no
difference in outcomes of MACE (111/1575 = 7% vs 16/
229 = 7% P = .97) and major bleeding (49/1575 = 3.1%
vs. 11/229 = 4.8% P = .18) when comparing cases based
on operator default preference.
Recent randomized controlled trials (RCTs) comparing
radial and femoral access in PPCI show conflicting results.
Three large trials have shown that use of RA in PPCI is
associated with lower mortality and fewer bleeding
complications.5,6,10 The largest and most recent trial,
MATRIX (Minimizing Adverse Haemorrhagic Events by
Transradial Access Site and Systemic Implementation of
angioX), randomized 8404 patients with acute coronary
syndrome to radial or femoral access and reported a
significant difference in all-cause mortality (1.6% vs 2.2%,
RR 0.72, 95% CI 0.53–0.99; P = .045) and major bleeding
(1.6% vs 2.3%; RR 0.67, 95% CI 0.49–0.92; P = .013).This
has reinforced a trend towards increased RA. RA is now
recommended as the preferred access site by ESC
Table I. Baseline characteristics and demographics for radial and femoral access sites
Radial access Femoral access
P(n = 1472) (n = 332)
Baseline characteristics
Age (years) 62.4+/−12.9 66.0+/−13.7 b.001
Body weight (kg) 80.5+/−17.9 77.7+/−18.4 .016
SBP on admission (mmHg) 137.4+/−27.4 130.1+/−30.3 b.001
eGFR (ml/kg/min) 76.0+/−16.0 69.8+/−20.1 b.001
Hemoglobin (g/dl) 13.6+/−1.6 13.2+/−1.8 b.001
Diabetes 195/1472 (13.2%) 53/332 (16%) .84
Previous MI 154/1472 (10.5%) 59/332 (17.8%) b.001
Previous CABG 16/1472 (1.1%) 26/332 (7.8%) b.001
Previous PCI 98/1472 (6.7%) 31/332 (9.3%) b.001
GPI Use 201/1471 (13.7%) 61/332 (18.4%) .03
Venous access use 32/1472 (2.2%) 33/331 (10.0%) b.001
IABP Use 37/1373 (2.7%) 22/305 (7.2%) .001
SBP, Systolic BP; eGFR, estimated glomerular filtration rate; CABG, coronary artery bypass grafting; MI, myocardial infarction; PCI, percutaneous coronary intervention; GPI,
glycoprotein inhibitors; IABP, intra-aortic balloon pump.
Table II. 28-day clinical outcomes by final site access
All radial All femoral
P(n = 1472) (n = 332)
MACE 91/1472 (6.2%) 36/332 (10.8%) .003
Mortality 55/1472 (3.7%) 27/332 (8.1%) .001
Major bleed 38/1472 (2.6%) 22/332 (6.6%) .001
Access site related 5/1472 (0.3%) 7/332 (2.1%) b.001
Minor bleed 118/1472 (8%) 62/332 (18.7%) b.001
Access site related 59/1472 (4.0%) 55/332 (16.6%) b.001
Any bleed 153/1472 (10.4%) 81/332 (24.4%) b.001
MACE, Major adverse cardiovascular events.
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shown no difference in outcomes between RA and FA.7,8
There are several possible reasons for these differing
results. Firstly, recent advances in technology, such as use
of vascular closure devices, have improved the safety of
FA.11 Secondly, RCTs often use different exclusion
criteria, definitions of clinical outcomes and doses of
antithrombotic medications which may affect the exter-
nal validity of the results. Thirdly, randomizing the access
site does not consider the skill level of the operator. A
recent observational trial of British Cardiovascular
Intervention Society (BCIS) data showed total procedural
volume and proportion of procedures undertaken radially
by an operator was associated with lower mortality in
patients undergoing PPCI via RA.12 Therefore, the
experience and familiarity of the operator is likely to
affect the outcomes of the patient. For an RCT to
compare the access sites in a useful way, operators would
have to be similar in their competence in using both RA
and FA. Few operators meet this requirement and mostRCTs do not consider operator or center experience.
Both MATRIX and RIVAL found that improvements in
outcomes in RA cases were only significant when
considering centers with high radial volume.6,10
Operators usually have a default access preference, in
which they are more experienced.9 This study compared
outcomes by default operator type, reflecting real-world
practice in a high-volume regional center. Patients,
therefore, benefitted from the clinical judgment exer-
cised by the operator in their choice of access site. The
results showed no significant difference in clinical
outcomes between radial and femoral operators, with
comparable baseline characteristics in the two groups.
Selection bias is likely to be minimal because patients
were allocated to the operator at random, based on a rota
system. These results suggest that FA may not be
associated with increased MACE when performed by
experienced femoral operators. In trials where the access
site is randomized, complications in FA cases could be
overestimated because the operator may have to perform
Figure 2
Flow diagram outlining the number of cases where access was gained by default femoral and default radial operators.
Table III. Baseline characteristics and demographics for default radial and default femoral operators
Radial operators Femoral operators
P(n = 1575) (n = 229)
Baseline characteristics
Age (years) 63.0+/−13.1 63.2+/−13.3 .86
Body weight (kg) 79.9+/−17.9 80.8+/−18.3 .48
SBP on admission (mmHg) 136.0+/−28.1 136.1+/−28.0 .92
eGFR (ml/kg/min) 75.0+/−16.9 73.8+/−17.4 .32
Hemoglobin (g/dl) 13.5+/−1.6 13.6+/−1.5 .59
Diabetes 213/1575 (13.5%) 35/229 (15.3%) .75
Previous MI 183/1575 (11.6%) 30/229 (13.1%) .66
Previous CABG 30/1575 (1.9%) 12/229 (5.2%) .006
Previous PCI 116/1575 (7.4%) 13/229 (5.7%) .48
GPI use 219/1574 (13.9%) 43/229 (18.8%) .05
Venous access use 61/1575 (3.9%) 16/228 (7.0%) .003
IABP use 53/1469 (3.6%) 6/219 (2.7%) .47
SBP, Systolic BP; eGFR, estimated glomerular filtration rate; CABG, coronary artery bypass grafting; MI, myocardial infarction; PCI, percutaneous coronary intervention; GPI,
glycoprotein inhibitors; IABP, intra-aortic balloon pump.
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normal clinical practice. As far as we know, this is the first
study analyzing outcomes by default operator type.
There have been multiple observational trials examin-
ing potential differences in outcomes when comparing
access sites in PCI.4,13,14 However, the circumstances and
conduct of the HEAT-PPCI study afford a, possibly,
unique opportunity to perform a comparison of the
strategies of default femoral and radial access, free from
much of the bias that normally confounds observational
research. The data used in this study are from an RCT,with rigorous tracking of events and high-quality data
collection. HEAT-PPCI used real-world, consecutive,
unselected cases, making participant selection more
reflective of routine practice.
A simple observational analysis of our data would
suggest that the performance of PPCI cases with RA is
associated with reduced incidence of mortality, MACE
and major bleeding. However, examination of the
baseline characteristics of patients grouped by final
access site shows a less favorable risk profile in patients
who had FA. Default radial operators only attempt
Table V. Baseline characteristics of participants where FA is used, by default operator type
Femoral cases by radial operators Femoral cases by femoral operators
P(n = 122) (n = 210)
Baseline characteristics
Age (years) 70.2+/− 13.8 63.7+/−13.0 b.001
Body weight (kg) 71.9+/−18.2 80.7+/−17.8 b.001
SBP on admission (mmHg) 121.1+/−33.0 135.2+/−27.6 b.001
eGFR (ml/kg/min) 63.6+/−22.8 73.8+/−19.4 b.001
Hemoglobin (g/dl) 12.6+/−2.0 13.5+/−1.5 b.001
Diabetes 22/122 (18%) 31/210 (14.8%) .19
Previous MI 32/122 (26.2%) 27/210 (12.9%) .002
Previous CABG 14/122 (11.5%) 12/210 (5.7%) .06
Previous PCI 19/122 (15.6%) 12/210 (5.7%) .003
GPI use 21/122 (17.2%) 40/210 (19%) .68
Venous access use 28/122(23.0%) 15/209 (7.2%) b.001
IABP use 17/114 (14.9%) 5/191 (2.6%) b.001
SBP, Systolic BP; eGFR, estimated glomerular filtration rate; CABG, coronary artery bypass grafting; MI, myocardial infarction; PCI, percutaneous coronary intervention; GPI,
glycoprotein inhibitors; IABP, intra-aortic balloon pump.
Table IV. Twenty-eight-day clinical outcomes by default radial and default femoral operators
Radial operators Femoral operators
P(n = 1575) (n = 229)
Outcomes
MACE 111/1575 (7%) 16/229 (7%) .97
Mortality 73/1575 (4.6%) 9/229 (3.9%) .63
Major bleed 49/1575 (3.1%) 11/229 (4.8%) .18
Access site related 8/1575 (0.5%) 4/229 (1.7%) .055
Minor bleed 142/1575 (9%) 38/229 (16.6%) b.001
Access site related 82/1575 (5.2%) 32/229 (14.0%) b.001
Any bleed 186/1575 (11.8%) 48/229 (21%) b.001
MACE, Major adverse cardiovascular events.
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are associated with higher risk. Such reasons include
circulatory collapse resulting in an impalpable pulse;
radial occlusion associated with previous procedures (a
marker of chronic or advanced disease); a requirement to
access bypass graft conduits and a need to access the
groin for reasons of intra-aortic balloon pump insertion or
placement of a temporary wire.
Some studies have suggested that procedures per-
formed through FA by radial operators have higher
complication rates.15,16 This seems logical because
increased experience with an access site leads to better
outcomes.12 However, a recent observational study
showed that a reduction in the number and proportion
of femoral cases is not associated with a loss of femoral
proficiency.17 This may be because although the radial
operators are more experienced in RA in uncomplicated
cases, in cases where the patient presents in cardiogenic
shock or hemodynamically unstable, they perform PCI
via FA and therefore maintain competency in the use ofFA in complex cases. Our study shows that cases
performed via FA had higher rates of MACE and major
bleeding when performed by default RA operators, but
the risk profile of these patients was less favorable. This
suggests that the overall clinical condition of the patient
may explain the increased incidence of MACE and major
bleeding, rather than the access site used or access skills
of the operator.
Limitations
The number of cases performed by the default femoral
operators (and the number of associated adverse events)
is low and hence it is difficult to characterize results in
this group with precision. There was no routine use of
radiographic guidance, micropuncture or ultrasound
imaging for femoral access during the trial. It is likely
use of a more fastidious technique would improve
outcomes for patients who have procedures performed
via FA. This is an analysis of observational data and
therefore cannot be used to infer a causal relationship
Table VI. Twenty-eight-day clinical outcomes in cases where FA was used, by default radial and default femoral operators
Radial operators Femoral operators
P(n = 122) (n = 210)
Outcomes
MACE 22/122 (18%) 14/210 (6.7%) .003
Mortality 20/122 (16.4%) 7/210 (3.3%) .001
Major bleed 11/122 (9%) 11/210 (5.2%) b.001
Access site related 3/122 (2.5%) 4/210 (1.9%) .71
Minor bleed 24/122 (19.7%) 38/210 (18.1%) .72
Access site related 23/122 (18.9%) 32/210 (15.2%) .45
Any bleed 33/122 (27%) 48/210 (22.9%) .39
MACE, Major adverse cardiovascular events.
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unmeasured confounding. HEAT-PPCI was a single center
study so the results are not necessarily generalizable to all
patient groups or operator experiences.Conclusion
Default femoral operators achieved comparable out-
comes compared to default radial operators. The less
favorable outcomes observed in FA cases may result from
its selective use by radial operators in high risk cases.
Further studies are required to establish the differences
between RA and FA since the introduction of vascular
closure devices and should compare the default operator
type as this would better reflect real-world practice.References
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